跳至主要内容
临床试验/CTRI/2024/08/072830
CTRI/2024/08/072830尚未招募2/3 期

Clinical comparative study to evaluate the potential of Marma Chikitsa and Agnikarma with Suvarna Shalaka as an intervention in the management of Janusandhigata vata w.s.r to Osteoarthritis of Knee

Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2024年9月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
1. Efficacy of Marma chikitsa

研究概览

简要总结

Osteoarthritis (OA) is one of the most common and disabling musculoskeletal disorder, which is extremely common in the elderly population. Osteoarthritis is a long-term chronic disease that involves the deterioration of cartilage in joints (which may be knee, hip, feet, hand, shoulder or spine), with the result that the bones start rubbing together, and cause pain, stiffness, and restriction of movement.

This study is to evaluate the effect of Marma therapy (study group) in the management of janu sandhigata vata w.s.r to osteoarthritis of knee and also to compare the effect of Marma therapy and Agnikarma with Suvarna shalaka in the management of janu sandhigata vata w.s.r to osteoarthritis of knee.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
40.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Age 40-70 years, irrespective of sex, religion and socio-economic status.
  • Patients having clinical features of Sandhigata Vata as described in ayurvedic scriptures, as well as clinical features of Osteoarthritis of knee Patients fit to undergo Marma therapy and Agnikarma and willing to sign the informed consent.

排除标准

  • Age <40years and >70 years Patients with grade 4 x ray findings.
  • Subjects suffering from any other type of arthritis like rheumatoid Arthritis, psoriatic arthritis.
  • Infective arthritis, gout, ankylosing spondylitis Subjects with any other serious systemic disorder, which may interference with the treatment Traumatic causes like fracture.
  • Pregnancy and lactation.

结局指标

主要结局

1. Efficacy of Marma chikitsa

时间窗: 30 days

2. Relief in symptoms

时间窗: 30 days

次要结局

  • 1.Acceptability/ Tolerance of treatment(2.Improved quality of life)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurveda University
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Anita lalwani

DSRRAU, karwar Jodhpur

研究点 (1)

Loading locations...

相似试验